In the CodeBreaK 300 trial, sotorasib and panitumumab had better response rates and improved PFS vs standard-of-care treatment options. M...

The approval marks the first in the US for the novel antibody drug conjugate. Medscape Medical News

There's a new nicotine alternative on the block, and consumers can't get enough. You've likely heard of e-cigarettes, vapes, and chewing tob...

Pivotal Study Demonstrated the Combination More Than Doubled Progression-Free Survival Compared to Investigated SOC THOUSAND OAKS, Calif., J...

The FDA urges manufacturers to revise labeling of transmucosal buprenorphine products to ease access to higher doses because of the rise of...

In English SILVER SPRING, MD, 16 de enero de 2025 /PRNewswire-HISPANIC PR WIRE/-- Hoy, la Administración de Alimentos y Medicamentos de los...

The administration OKed 10 Zyn flavors, including coffee, mint and menthol.

WASHINGTON — Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris Internati...

Food manufacturers will have until 2027 to stop using the dye. Drugmakers have until 2028.

By MATTHEW PERRONE, AP Health WriterWASHINGTON (AP) — Federal health officials on Thursday backed the public health benefits of nicotine po...

The Food and Drug Administration (FDA) granted a 2022 petition by consumer advocacy groups to ban the use of the dye.

Regulators banned a dye called Red 3 from the U.S. food supply, but the timing for its removal won’t be immediate. According to the Food...

– U.S. launch expected in early February – – Niktimvo is the first and only approved treatment for chronic GVHD that targets CSF-1R to reduc...